RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Pengfei Yu(Chinese Academy of Sciences), Malay Haldar(University of Pennsylvania)
Cited by 4
Related Papers
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models
|Science Translational Medicine|2021|139
Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis
|Oncogene|2016|83
Characterization of Lgr5+ Progenitor Cell Transcriptomes after Neomycin Injury in the Neonatal Mouse Cochlea
|Frontiers in Molecular Neuroscience|2017|39